A Diagnosis Just in Time
Joshua Osborn was fighting for his life against a mysterious ailment. With his options dwindling, a team at UCSF employed advanced DNA sequencing technology to track down the culprit.
University of California San Francisco
Give to UCSFJoshua Osborn was fighting for his life against a mysterious ailment. With his options dwindling, a team at UCSF employed advanced DNA sequencing technology to track down the culprit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
Researchers are harnessing the power of the body's natural defenses to fight deadly cancers, and the treatment appears to be powerful, effective and long-lasting.
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
Children’s risk for developing allergies and asthma is reduced when they are exposed in early infancy to a dog in the household, and now researchers have discovered a reason why.
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
A new link between meal times and daily changes in the immune system has been identified by UCSF researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.
Scientists from UCSF have identified a new way to manipulate the immune system that may keep it from attacking the body’s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.
A protein at the center of Parkinson’s disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis.
Adenoviruses commonly infect humans, causing colds, flu-like symptoms and sometimes even death, but now UCSF researchers have discovered that a new species of adenovirus can spread from primate to primate, and potentially from monkey to human.
Raising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
DNA sequences obtained from a handful of patients with multiple sclerosis at the UCSF Medical Center have revealed the existence of an “immune exchange” that allows the disease-causing cells to move in and out of the brain.